Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retreatment of recurrent Dupuytren's contracture joints with XIAFLEX/XIAPEX after prior successful Phase 3 treatment
2011-005065-21Phase 4Completed
- Sponsor
- Auxilium UK Limited
- Start
- Feb 2012
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Auxilium UK Limited. Primary endpoints: Flexion deformity of recurrent joint, Range of motion of recurrent joint and 2 more. Started Feb 2012; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on 2011-005065-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005065-21.